Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk-Jan Guchelaar

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
European Journal of Human Genetics : EJHG|July 4, 2018
Pharmacogenomics, a novel section in the European Journal of Human GeneticsHenk-Jan Guchelaar
Pharmacy World & Science : PWS|July 5, 2003
Risk and the sense of safetyHenk-Jan Guchelaar
Current Pharmaceutical Design|March 11, 2010
Pharmacogenetics: current status and future perspectivesHenk-Jan Guchelaar
Basic & Clinical Pharmacology & Toxicology|August 18, 2023
Reply to: Temporary Like Achilles: Pre-emptive germline pharmacogenetic testingHenk-Jan Guchelaar, Jesse Swen
Frontiers in Immunology|July 5, 2022
Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable PatientsRomy Mosch, Henk-Jan Guchelaar
Clinical and Translational Science|December 31, 2025
Pre-Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta-Analysis and RecommendationTessa Goedhart, Henk-Jan Guchelaar
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene ExpressionHenok D Habtemariam, Henk-Jan Guchelaar
Pharmacogenomics|April 3, 2012
Just how feasible is pharmacogenetic testing in the primary healthcare setting?Jesse J Swen, Henk Jan Guchelaar
Drug Discovery Today|August 7, 2024
The efficacy and safety of eculizumab in patients and the role of C5 polymorphismsHendrikus Bernhard Bouwman, Henk-Jan Guchelaar
Pharmacy World & Science : PWS|July 5, 2003
Risk assessment in clinical pharmacyPatrick T Hudson, Henk-Jan Guchelaar
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
European Journal of Human Genetics : EJHG|July 4, 2018
Pharmacogenomics, a novel section in the European Journal of Human GeneticsHenk-Jan Guchelaar
Pharmacy World & Science : PWS|July 5, 2003
Risk and the sense of safetyHenk-Jan Guchelaar
Current Pharmaceutical Design|March 11, 2010
Pharmacogenetics: current status and future perspectivesHenk-Jan Guchelaar
Basic & Clinical Pharmacology & Toxicology|August 18, 2023
Reply to: Temporary Like Achilles: Pre-emptive germline pharmacogenetic testingHenk-Jan Guchelaar, Jesse Swen
Frontiers in Immunology|July 5, 2022
Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable PatientsRomy Mosch, Henk-Jan Guchelaar
Clinical and Translational Science|December 31, 2025
Pre-Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta-Analysis and RecommendationTessa Goedhart, Henk-Jan Guchelaar
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene ExpressionHenok D Habtemariam, Henk-Jan Guchelaar
Pharmacogenomics|April 3, 2012
Just how feasible is pharmacogenetic testing in the primary healthcare setting?Jesse J Swen, Henk Jan Guchelaar
Drug Discovery Today|August 7, 2024
The efficacy and safety of eculizumab in patients and the role of C5 polymorphismsHendrikus Bernhard Bouwman, Henk-Jan Guchelaar
Pharmacy World & Science : PWS|July 5, 2003
Risk assessment in clinical pharmacyPatrick T Hudson, Henk-Jan Guchelaar
Pageof 38